News AZ sells rights to three older drugs to Covis for $350m Richard Staines AstraZeneca, inflammation, rhinitis 0 Comment AstraZeneca has agreed to sell rights to three older drugs for asthma and rhinitis to Covis Pharma for Share X AZ sells rights to three older drugs to Covis for $350m https://pharmaphorum.com/news/az-sells-rights-to-three-older-drugs-to-covis-for-350m/
